Epothilones [clinicaltrials_resource:5deafdf8690b4ecb52225480c10a3349]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [clinicaltrials:NCT00021099]BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00022542]BMS-247550 in Treating Patients With Liver or Gallbladder Cancer [clinicaltrials:NCT00023946]clinicaltrials:NCT00025155BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00028561]A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors [clinicaltrials:NCT00030173]EPO906 Therapy in Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00035087]EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer [clinicaltrials:NCT00035100]EPO906 Therapy in Patients With Prostate Cancer [clinicaltrials:NCT00035113]EPO906 Therapy in Patients With Advanced Breast Cancer [clinicaltrials:NCT00035126]EPO906 Therapy in Patients With Advanced Melanoma [clinicaltrials:NCT00035165]EPO906 Therapy in Patients With Advanced Kidney Cancer [clinicaltrials:NCT00035243]A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy [clinicaltrials:NCT00035516]BMS-247550 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00036764]EPO906 in Carcinoid and Other Neuroendocrine Tumors [clinicaltrials:NCT00050349]clinicaltrials:NCT00058019Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer [clinicaltrials:NCT00077259]clinicaltrials:NCT00080301Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy [clinicaltrials:NCT00081107]clinicaltrials:NCT00082433Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer [clinicaltrials:NCT00299390]Ixabepilone Administered as an Enteric Coated Formulation. [clinicaltrials:NCT00309049]Ixabepilone, Mitoxantrone Hydrochloride, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy [clinicaltrials:NCT00331344]Ixabepilone in Treating Young Patients With Refractory Solid Tumors [clinicaltrials:NCT00331643]A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer. [clinicaltrials:NCT00337649]clinicaltrials:NCT00370552Epothilone in Recurrent Glioblastoma Patients [clinicaltrials:NCT00397072]Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies [clinicaltrials:NCT00420615]clinicaltrials:NCT00422097Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) [clinicaltrials:NCT00442741]clinicaltrials:NCT00450866clinicaltrials:NCT00490646clinicaltrials:NCT00546364clinicaltrials:NCT00593827clinicaltrials:NCT00633464clinicaltrials:NCT00634088clinicaltrials:NCT00683904clinicaltrials:NCT00741988Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) [clinicaltrials:NCT00751205]FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC [clinicaltrials:NCT00751868]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Epothilones [clinicaltrials_resource:5deafdf8690b4ecb52225480c10a3349]
Bio2RDF identifier
5deafdf8690b4ecb52225480c10a3349
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5deafdf8690b4ecb52225480c10a3349
identifier
clinicaltrials_resource:5deafdf8690b4ecb52225480c10a3349
title
Epothilones
@en
type
label
Epothilones [clinicaltrials_resource:5deafdf8690b4ecb52225480c10a3349]
@en